SCHEMBL13702129

SCHEMBL13702129

CC(C)NC(=O)c1cc(F)cc(F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.55
NPSR1 Q6W5P4 1/20 0.49
SLC6A3 Q01959 1/20 0.49
CES2 O00748 2/20 0.48
CES1 P23141 2/20 0.48
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRM5 P41594 1/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42
PTGS2 P35354 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26712444 0.89 TAS1R3 (0.49) MLYCDNPSR1SLC6A3NPC1SMN1; SMN2
SCHEMBL23984461 0.87 TAS1R3 (0.54) MLYCDNPSR1NPC1RAB9ASMN1; SMN2
SCHEMBL13753151 0.84 NPSR1 (0.63) MLYCDNPSR1CES2CYP1A2CYP2C19
SCHEMBL4443226 0.84 MLYCD (0.53) MLYCDNPSR1ALDH1A1LMNACYP1A2
SCHEMBL24571660 0.84 TAS1R3 (0.49) MLYCDSLC6A3CES2CES1NPC1
SCHEMBL31360472 0.82 CA2 (0.49) SLC6A3CES2CES1NPC1SMN1; SMN2
SCHEMBL16987308 0.82 ANPEP (0.52) MLYCDNPSR1CES2CES1ALDH1A1
SCHEMBL13702132 0.81 NPSR1 (0.64) MLYCDNPSR1CES2CES1NPC1
SCHEMBL29518963 0.81 NPSR1 (0.64) MLYCDNPSR1CES2CES1NPC1
SCHEMBL24571248 0.81 MAPK1 (0.58) MLYCDSLC6A3CES2CES1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140390-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2022-06-30 WO disclosed
WO-2021013561-A1 PESTICIDAL PYRAZOLE AND TRIAZOLE DERIVATIVES BASF SE (DE) 2021-01-28 WO disclosed
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 US disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX MLYCD 2152/4885NPSR1 3715/4885SLC6A3 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.